Market Overview

Targeted Medical Pharma to Present at Upcoming Investor Conferences

Share:
LOS ANGELES--(BUSINESS WIRE)--

Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing facilities, today announced that members of its executive team are scheduled to present and conduct one-on-one meetings at the following investor conferences:

  • Wednesday, November 7, 2012
    14th Annual SoCal Bio Conference & Exhibition
    Omni Hotel – 251 South Olive Street, Los Angeles, CA
    2:00 p.m. Eastern Time (11:00 a.m. Pacific Time)


  • Thursday, November 29, 2012
    New York Society of Security Analysts' (NYSSA) 16th Annual Investing in Life Sciences Conference
    NYSSA Conference Facilities – 1540 Broadway, New York, NY
    1:30 p.m. Eastern Time (10:30 a.m. Pacific Time)


A live webcast of the NYSSA presentation will be available at the company's website at www.tmedpharma.com.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of chronic disease including pain syndromes, obesity, sleep and cognitive disorders. The company manufactures nine proprietary prescription only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical. These prescription medical food products and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. Based in Los Angeles, the company's proprietary pharmaceutical therapeutic systems are currently sold in the United States and Japan. Targeted Medical Pharma also provides billing and collection services on behalf of dispensing physicians.

Media Contacts:
PondelWilkinson
George Medici | gmedici@pondel.com
Ron Neal | rneal@pondel.com
(310) 279-5980
or
Investor Contacts:
PondelWilkinson
Roger Pondel | Matt Sheldon
investors@tmedpharma.com
(310) 279-5975









View Comments and Join the Discussion!